Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach): Randomized Clinical Trial
proximal ultrasound-guided GON radiofrequency ablation
+ distal ultrasound-guided GON radiofrequency ablation
Treatment Study
Summary
Study start date: January 1, 2022
Actual date on which the first participant was enrolled.This study explores a new way to help people who suffer from a combination of migraine and cervicogenic headaches, which are headaches that originate in the neck. Traditional treatments usually involve medications, but sometimes these don't work well enough. For those who have not found relief with drugs, there is growing interest in targeting the greater occipital nerve, a nerve involved in head and neck pain. This study is important because it investigates the use of radiofrequency ablation, a method that uses heat to disrupt pain signals, as a potential solution for those whose headaches don't respond to usual treatments. Participants in this study will receive treatment through a process called pulsed radiofrequency, which involves using ultrasound guidance to precisely target the greater occipital nerve. This procedure aims to lessen pain by interfering with the nerve's ability to send pain signals. The study will monitor how well this method works in providing relief from headaches. While the potential benefits include significant pain reduction, the study will also consider any risks associated with the procedure. The results could offer a new option for those struggling with chronic headaches that don't respond to standard treatments.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location